David C Kaelber1,2,3, Weiwei Liu4,5, Michelle Ross4,6, A Russell Localio4,6, Janeen B Leon4,3, Wilson D Pace4,7, Richard C Wasserman4,5,8, Alexander G Fiks4,5,9,10,11,12. 1. Comparative Effectiveness Research Through Collaborative Electronic Reporting (CER) Consortium Research Team, Elk Grove Village; Illinois; david.kaelber@case.edu. 2. Departments of Internal Medicine, Pediatrics, Epidemiology, and Biostatistics, Case Western Reserve University, Cleveland Ohio. 3. Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio. 4. Comparative Effectiveness Research Through Collaborative Electronic Reporting (CER) Consortium Research Team, Elk Grove Village; Illinois. 5. Pediatric Research in Office Settings, American Academy of Pediatrics, Elk Grove Village, Illinois. 6. Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. 7. American Academy of Family Physicians National Research Network, Leawood, Kansas. 8. Department of Pediatrics, University of Vermont College of Medicine, Burlington, Vermont; and. 9. The Pediatric Research Consortium. 10. Department of Biomedical and Health Informatics. 11. Center for Pediatric Clinical Effectiveness, and. 12. PolicyLab, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Abstract
BACKGROUND AND OBJECTIVES: Pediatric hypertension predisposes children to adult hypertension and early markers of cardiovascular disease. No large-scale studies have examined diagnosis and initial medication management of pediatric hypertension and prehypertension. The objective of this study was to evaluate diagnosis and initial medication management of pediatric hypertension and prehypertension in primary care. METHODS: Retrospective cohort study aggregating electronic health record data on >1.2 million pediatric patients from 196 ambulatory clinics across 27 states. Demographic, diagnosis, blood pressure (BP), height, weight, and medication prescription data extracted. Main outcome measures include proportion of pediatric patients with ≥3 visits with abnormal BPs, documented hypertension and prehypertension diagnoses, and prescribed antihypertensive medications. Marginal standardization via logistic regression produced adjusted diagnosis rates. RESULTS: Three hundred ninety-eight thousand seventy-nine patients, ages 3 to 18, had ≥3 visits with BP measurements (48.9% girls, 58.6% <10 years old). Of these, 3.3% met criteria for hypertension and 10.1% for prehypertension. Among practices with ≥50 eligible patients, 2813 of 12 138 patients with hypertension (23.2%; 95% confidence interval, 18.2%-28.2%) and 3990 of 38 874 prehypertensive patients (10.2%; 95% confidence interval, 8.2%-12.2%) were diagnosed. Age, weight, height, sex, and number and magnitude of abnormal BPs were associated with diagnosis rates. Of 2813 diagnosed, persistently hypertensive patients, 158 (5.6%) were prescribed antihypertensive medication within 12 months of diagnosis (angiotensin-converting enzyme inhibitors/angiotensin receptive blockers [35%], diuretics [22%], calcium channel blockers [17%], and β-blockers [10%]). CONCLUSIONS: Hypertension and prehypertension were infrequently diagnosed among pediatric patients. Guidelines for diagnosis and initial medication management of abnormal BP in pediatric patients are not routinely followed.
BACKGROUND AND OBJECTIVES:Pediatric hypertension predisposes children to adult hypertension and early markers of cardiovascular disease. No large-scale studies have examined diagnosis and initial medication management of pediatric hypertension and prehypertension. The objective of this study was to evaluate diagnosis and initial medication management of pediatric hypertension and prehypertension in primary care. METHODS: Retrospective cohort study aggregating electronic health record data on >1.2 million pediatric patients from 196 ambulatory clinics across 27 states. Demographic, diagnosis, blood pressure (BP), height, weight, and medication prescription data extracted. Main outcome measures include proportion of pediatric patients with ≥3 visits with abnormal BPs, documented hypertension and prehypertension diagnoses, and prescribed antihypertensive medications. Marginal standardization via logistic regression produced adjusted diagnosis rates. RESULTS: Three hundred ninety-eight thousand seventy-nine patients, ages 3 to 18, had ≥3 visits with BP measurements (48.9% girls, 58.6% <10 years old). Of these, 3.3% met criteria for hypertension and 10.1% for prehypertension. Among practices with ≥50 eligible patients, 2813 of 12 138 patients with hypertension (23.2%; 95% confidence interval, 18.2%-28.2%) and 3990 of 38 874 prehypertensivepatients (10.2%; 95% confidence interval, 8.2%-12.2%) were diagnosed. Age, weight, height, sex, and number and magnitude of abnormal BPs were associated with diagnosis rates. Of 2813 diagnosed, persistently hypertensivepatients, 158 (5.6%) were prescribed antihypertensive medication within 12 months of diagnosis (angiotensin-converting enzyme inhibitors/angiotensin receptive blockers [35%], diuretics [22%], calcium channel blockers [17%], and β-blockers [10%]). CONCLUSIONS:Hypertension and prehypertension were infrequently diagnosed among pediatric patients. Guidelines for diagnosis and initial medication management of abnormal BP in pediatric patients are not routinely followed.
Authors: Scott M Sutherland; David C Kaelber; N Lance Downing; Veena V Goel; Christopher A Longhurst Journal: Pediatr Clin North Am Date: 2016-04 Impact factor: 3.278
Authors: Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Vital Health Stat 11 Date: 2002-05
Authors: Perdita Taylor-Zapata; Carissa M Baker-Smith; Gilbert Burckart; Stephen R Daniels; Joseph T Flynn; George Giacoia; Dionna Green; Aaron S Kelly; Mona Khurana; Jennifer S Li; Charlotte Pratt; Elaine M Urbina; Anne Zajicek Journal: Pediatrics Date: 2019-05 Impact factor: 7.124
Authors: Pablo Florenzano; Iris R Hartley; Macarena Jimenez; Kelly Roszko; Rachel I Gafni; Michael T Collins Journal: Calcif Tissue Int Date: 2020-06-05 Impact factor: 4.333
Authors: Elyse O Kharbanda; Steve E Asche; Alan R Sinaiko; Heidi L Ekstrom; James D Nordin; Nancy E Sherwood; Patricia L Fontaine; Steven P Dehmer; Deepika Appana; Patrick O'Connor Journal: Pediatrics Date: 2018-02 Impact factor: 7.124
Authors: Elyse O Kharbanda; Steve E Asche; Steven P Dehmer; Alan R Sinaiko; Heidi L Ekstrom; Nicole Trower; Patrick J O'Connor Journal: J Clin Hypertens (Greenwich) Date: 2019-04-13 Impact factor: 3.738
Authors: Min Zhao; Jose G Mill; Wei-Li Yan; Young Mi Hong; Paula Skidmore; Lee Stoner; Ana I Mora-Urda; Anuradha Khadilkar; Rafael de Oliveira Alvim; Hae Soon Kim; Pilar Montero López; Yi Zhang; Pouya Saeedi; Divanei Zaniqueli; Yuan Jiang; Polyana Romano Oliosa; Eliane Rodrigues de Faria; Kai Mu; Da-Yan Niu; Costan G Magnussen; Bo Xi Journal: J Clin Hypertens (Greenwich) Date: 2019-08-07 Impact factor: 3.738